Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Balance Sheet

GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Balance Sheet History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
EQUITY AND LIABILITIES
Share Capital ₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr
    Equity - Authorised ₹50 Cr₹50 Cr₹50 Cr₹50 Cr₹50 Cr
    Equity - Issued ₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr
    Equity Paid Up ₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr
    Equity Shares Forfeited -----
    Adjustments to Equity -----
    Preference Capital Paid Up -----
    Face Value ₹1.00₹1.00₹1.00₹1.00₹1.00
Share Warrants & Outstandings ₹0.05 Cr₹1.38 Cr₹1.67 Cr₹13 Cr₹25 Cr
Total Reserves ₹9,134 Cr₹8,706 Cr₹7,941 Cr₹7,128 Cr₹5,861 Cr
    Securities Premium ₹1,933 Cr₹1,929 Cr₹1,928 Cr₹1,895 Cr₹1,840 Cr
    Capital Reserves -----
    Profit & Loss Account Balance ₹7,157 Cr₹6,788 Cr₹6,015 Cr₹5,234 Cr₹4,023 Cr
    General Reserves ₹3.12 Cr₹3.12 Cr₹3.12 Cr₹3.12 Cr₹3.12 Cr
    Other Reserves ₹41 Cr₹-14 Cr₹-6.35 Cr₹-4.91 Cr₹-4.45 Cr
Reserve excluding Revaluation Reserve ₹9,134 Cr₹8,706 Cr₹7,941 Cr₹7,128 Cr₹5,861 Cr
Revaluation reserve -----
Shareholder's Funds ₹9,151 Cr₹8,724 Cr₹7,959 Cr₹7,158 Cr₹5,903 Cr
Minority Interest -----
Long-Term Borrowings -----
Secured Loans -----
    Non Convertible Debentures -----
    Converible Debentures & Bonds -----
    Packing Credit - Bank -----
    Inter Corporate & Security Deposit -----
    Term Loans - Banks -----
    Term Loans - Institutions -----
    Other Secured -----
Unsecured Loans ₹78 Cr₹107 Cr₹3.26 Cr₹3.82 Cr₹3.93 Cr
    Fixed Deposits - Public -----
    Loans and advances from subsidiaries -----
    Inter Corporate Deposits (Unsecured) -----
    Foreign Currency Convertible Notes -----
    Long Term Loan in Foreign Currency -----
    Loans - Banks ₹97 Cr₹136 Cr---
    Loans - Govt. -----
    Loans - Others -----
    Other Unsecured Loan ₹-19 Cr₹-29 Cr₹3.26 Cr₹3.82 Cr₹3.93 Cr
Deferred Tax Assets / Liabilities ₹163 Cr₹170 Cr₹84 Cr₹88 Cr₹74 Cr
    Deferred Tax Assets ₹70 Cr₹67 Cr₹23 Cr₹7.65 Cr₹6.02 Cr
    Deferred Tax Liability ₹233 Cr₹237 Cr₹107 Cr₹95 Cr₹80 Cr
Other Long Term Liabilities ₹71 Cr₹75 Cr₹2.22 Cr₹2.39 Cr₹2.50 Cr
Long Term Trade Payables -----
Long Term Provisions ₹146 Cr₹137 Cr---
Total Non-Current Liabilities ₹457 Cr₹489 Cr₹90 Cr₹94 Cr₹80 Cr
Current Liabilities -----
Trade Payables ₹820 Cr₹768 Cr₹587 Cr₹463 Cr₹396 Cr
    Sundry Creditors ₹820 Cr₹768 Cr₹587 Cr₹463 Cr₹396 Cr
    Acceptances -----
    Due to Subsidiaries- Trade Payables -----
Other Current Liabilities ₹620 Cr₹520 Cr₹109 Cr₹76 Cr₹62 Cr
    Bank Overdraft / Short term credit -----
    Advances received from customers ₹192 Cr₹85 Cr₹76 Cr₹34 Cr₹34 Cr
    Interest Accrued But Not Due -----
    Share Application Money -----
    Current maturity of Debentures & Bonds -----
    Current maturity - Others -----
    Other Liabilities ₹428 Cr₹435 Cr₹33 Cr₹43 Cr₹28 Cr
Short Term Borrowings -----
    Secured ST Loans repayable on Demands -----
    Working Capital Loans- Sec -----
    Buyers Credits - Unsec -----
    Commercial Borrowings- Unsec -----
    Other Unsecured Loans -----
Short Term Provisions ₹125 Cr₹111 Cr₹32 Cr₹43 Cr₹54 Cr
    Proposed Equity Dividend -----
    Provision for Corporate Dividend Tax -----
    Provision for Tax ₹74 Cr₹52 Cr₹0.99 Cr₹18 Cr₹29 Cr
    Provision for post retirement benefits -----
    Preference Dividend -----
    Other Provisions ₹51 Cr₹59 Cr₹31 Cr₹25 Cr₹25 Cr
Total Current Liabilities ₹1,565 Cr₹1,398 Cr₹729 Cr₹582 Cr₹513 Cr
Total Liabilities ₹11,173 Cr₹10,611 Cr₹8,778 Cr₹7,834 Cr₹6,496 Cr
ASSETS
Gross Block ₹5,613 Cr₹5,012 Cr₹2,295 Cr₹2,081 Cr₹1,431 Cr
Less: Accumulated Depreciation ₹1,466 Cr₹1,065 Cr₹724 Cr₹579 Cr₹476 Cr
Less: Impairment of Assets -----
Net Block ₹4,147 Cr₹3,947 Cr₹1,571 Cr₹1,502 Cr₹954 Cr
Lease Adjustment A/c -----
Capital Work in Progress ₹151 Cr₹238 Cr₹177 Cr₹181 Cr₹338 Cr
Non Current Investments -----
Long Term Investment -----
    Quoted -----
    Unquoted -----
Long Term Loans & Advances ₹88 Cr₹119 Cr₹129 Cr₹286 Cr₹78 Cr
Other Non Current Assets ₹4.43 Cr₹662 Cr-₹2.21 Cr₹2.43 Cr
Total Non-Current Assets ₹4,390 Cr₹4,966 Cr₹1,877 Cr₹1,982 Cr₹1,372 Cr
Current Assets Loans & Advances -----
Currents Investments ---₹155 Cr-
    Quoted -----
    Unquoted ---₹155 Cr-
Inventories ₹1,685 Cr₹1,655 Cr₹1,945 Cr₹1,186 Cr₹1,275 Cr
    Raw Materials ₹526 Cr₹459 Cr₹979 Cr₹466 Cr₹530 Cr
    Work-in Progress ₹437 Cr₹543 Cr₹461 Cr₹444 Cr₹364 Cr
    Finished Goods ₹90 Cr₹82 Cr₹82 Cr₹46 Cr₹170 Cr
    Packing Materials ₹506 Cr₹455 Cr₹361 Cr₹176 Cr₹172 Cr
    Stores  and Spare ₹115 Cr₹101 Cr₹41 Cr₹39 Cr₹33 Cr
    Other Inventory ₹12 Cr₹15 Cr₹20 Cr₹15 Cr₹6.33 Cr
Sundry Debtors ₹1,517 Cr₹1,559 Cr₹871 Cr₹1,075 Cr₹671 Cr
    Debtors more than Six months ₹24 Cr₹27 Cr₹299 Cr₹12 Cr₹111 Cr
    Debtors Others ₹1,512 Cr₹1,551 Cr₹631 Cr₹1,068 Cr₹561 Cr
Cash and Bank ₹2,556 Cr₹1,839 Cr₹3,771 Cr₹3,093 Cr₹3,006 Cr
    Cash in hand ₹0.02 Cr₹0.01 Cr₹0.01 Cr₹0.02 Cr₹0.02 Cr
    Balances at Bank ₹2,556 Cr₹1,839 Cr₹3,771 Cr₹3,093 Cr₹3,006 Cr
    Other cash and bank balances -----
Other Current Assets ₹150 Cr₹103 Cr₹91 Cr₹97 Cr₹84 Cr
    Interest accrued on Investments ₹98 Cr₹48 Cr₹66 Cr₹47 Cr₹39 Cr
    Interest accrued on Debentures -----
    Deposits with Government -----
    Interest accrued and or due on loans -----
    Prepaid Expenses ₹39 Cr₹38 Cr₹14 Cr₹14 Cr₹11 Cr
    Other current_assets ₹13 Cr₹16 Cr₹12 Cr₹36 Cr₹34 Cr
Short Term Loans and Advances ₹875 Cr₹489 Cr₹222 Cr₹247 Cr₹88 Cr
    Advances recoverable in cash or in kind ₹183 Cr₹112 Cr₹120 Cr₹178 Cr₹13 Cr
    Advance income tax and TDS -----
    Amounts due from directors -----
    Due From Subsidiaries -----
    Inter corporate deposits -----
    Corporate Deposits -----
    Other Loans & Advances ₹692 Cr₹378 Cr₹102 Cr₹68 Cr₹75 Cr
Total Current Assets ₹6,783 Cr₹5,645 Cr₹6,901 Cr₹5,852 Cr₹5,124 Cr
Net Current Assets (Including Current Investments) ₹5,218 Cr₹4,247 Cr₹6,172 Cr₹5,270 Cr₹4,611 Cr
Miscellaneous Expenses not written off -----
Total Assets ₹11,173 Cr₹10,611 Cr₹8,778 Cr₹7,834 Cr₹6,496 Cr
Contingent Liabilities ₹21 Cr₹16 Cr₹22 Cr₹13 Cr₹75 Cr
Total Debt ₹269 Cr₹320 Cr₹3.82 Cr₹3.93 Cr₹4.07 Cr
Book Value -529.56483.12434.84359.30
Adjusted Book Value 555.40529.56483.12434.84359.30

Compare Balance Sheet of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹36,253.0 Cr -4.7% 1.8% 29.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,667.0 Cr 1.4% -4.5% 6.5% Stock Analytics
DIVIS LABORATORIES ₹176,805.0 Cr 0.1% -2.5% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,554.0 Cr -2.7% 1.2% 39.3% Stock Analytics
CIPLA ₹109,120.0 Cr -2.3% -5.3% -9.8% Stock Analytics
DR REDDYS LABORATORIES ₹105,920.0 Cr -0.5% -4.7% -5.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-4.7%

1.8%

29.7%

SENSEX

4.3%

2.6%

-6.4%


You may also like the below Video Courses